FDA.reportPublic FDA data

venlafaxine 112.5 MG (as venlafaxine besylate monohydrate 183.95 MG) 24 HR Extended Release Oral Tablet

RxCUI
2605950
RxNorm name
venlafaxine 112.5 MG (as venlafaxine besylate monohydrate 183.95 MG) 24 HR Extended Release Oral Tablet
Display name
venlafaxine 112.5 MG (as venlafaxine besylate monohydrate 183.95 MG) 24 HR Extended Release Oral Tablet
Full name
venlafaxine 112.5 MG (as venlafaxine besylate monohydrate 183.95 MG) 24 HR Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e81a2daf-b8b2-7c05-b532-bc775700b100venlafaxine 112.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR venlafaxine 112.5 MG Extended Release Oral Tablet [SCD] · venlafaxine 112.5 MG (as venlafaxine besylate monohydrate 183.95 MG) 24 HR Extended Release Oral Tablet [SY]34These highlights do not include all the information needed to use VENLAFAXINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for VENLAFAXINE EXTENDED-RELEASE TABLETS. VENLAFAXINE extended-release tablets, for oral use Initial U.S. Approval: 199320251009